These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19418216)

  • 1. Silica-gold nanoshells as potential intraoperative molecular probes for HER2-overexpression in ex vivo breast tissue using near-infrared reflectance confocal microscopy.
    Bickford LR; Agollah G; Drezek R; Yu TK
    Breast Cancer Res Treat; 2010 Apr; 120(3):547-55. PubMed ID: 19418216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoconjugated gold nanoshell-mediated photothermal ablation of trastuzumab-resistant breast cancer cells.
    Carpin LB; Bickford LR; Agollah G; Yu TK; Schiff R; Li Y; Drezek RA
    Breast Cancer Res Treat; 2011 Jan; 125(1):27-34. PubMed ID: 20217215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid Stereomicroscopic Imaging of HER2 Overexpression in Ex Vivo Breast Tissue Using Topically Applied Silica-Based Gold Nanoshells.
    Bickford LR; Langsner RJ; Chang J; Kennedy LC; Agollah GD; Drezek R
    J Oncol; 2012; 2012():291898. PubMed ID: 23133450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of imprint cytology for assessment of surgical margins in lumpectomy specimens of breast cancer patients.
    Bakhshandeh M; Tutuncuoglu SO; Fischer G; Masood S
    Diagn Cytopathol; 2007 Oct; 35(10):656-9. PubMed ID: 17854083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulsed-laser irradiation of multifunctional gold nanoshells to overcome trastuzumab resistance in HER2-overexpressing breast cancer.
    Nunes T; Pons T; Hou X; Van Do K; Caron B; Rigal M; Di Benedetto M; Palpant B; Leboeuf C; Janin A; Bousquet G
    J Exp Clin Cancer Res; 2019 Jul; 38(1):306. PubMed ID: 31299997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
    Tan M; Yao J; Yu D
    Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Her2-Neu expression in ductal adenocarcinomas of the breast gland: correlation with histopathological parameters and estrogen receptors' expression in Mexican patients].
    Brück P; Vilches Cisneros N; Ramos López E; Barboza Quintana O; Ancer Rodríguez J; Flores Gutiérrez JP
    Ginecol Obstet Mex; 2006 Oct; 74(10):516-22. PubMed ID: 21961357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery.
    Cabioglu N; Hunt KK; Sahin AA; Kuerer HM; Babiera GV; Singletary SE; Whitman GJ; Ross MI; Ames FC; Feig BW; Buchholz TA; Meric-Bernstam F
    Ann Surg Oncol; 2007 Apr; 14(4):1458-71. PubMed ID: 17260108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-operative touch preparation cytology; does it have a role in re-excision lumpectomy?
    Valdes EK; Boolbol SK; Cohen JM; Feldman SM
    Ann Surg Oncol; 2007 Mar; 14(3):1045-50. PubMed ID: 17206481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative touch preparation cytology for margin assessment in breast-conservation surgery: does it work for lobular carcinoma?
    Valdes EK; Boolbol SK; Ali I; Feldman SM; Cohen JM
    Ann Surg Oncol; 2007 Oct; 14(10):2940-5. PubMed ID: 17632761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of HER2 overexpression in metastatic malignant melanoma.
    Inman JL; Kute T; White W; Pettenati M; Levine EA
    J Surg Oncol; 2003 Oct; 84(2):82-8. PubMed ID: 14502781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous analysis of c-erbB-2 expression and DNA content in breast cancer using flow cytometry.
    Stål O; Sullivan S; Sun XF; Wingren S; Nordenskjöld B
    Cytometry; 1994 Jun; 16(2):160-8. PubMed ID: 7924685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of intraoperative gross examination of surgical margin status in women undergoing partial mastectomy for breast malignancy.
    Balch GC; Mithani SK; Simpson JF; Kelley MC
    Am Surg; 2005 Jan; 71(1):22-7; discussion 27-8. PubMed ID: 15757052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoshell-enabled photothermal cancer therapy: impending clinical impact.
    Lal S; Clare SE; Halas NJ
    Acc Chem Res; 2008 Dec; 41(12):1842-51. PubMed ID: 19053240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentials and pitfalls of gold-silica nanoshell as the exogenous contrast agent for optical diagnosis of cancers: a numerical parametric study.
    Xu X
    Lasers Med Sci; 2019 Apr; 34(3):615-628. PubMed ID: 30350124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of in vivo near-infrared laser confocal endomicroscopy with indocyanine green to detect the boundary of infiltrative tumor.
    Martirosyan NL; Cavalcanti DD; Eschbacher JM; Delaney PM; Scheck AC; Abdelwahab MG; Nakaji P; Spetzler RF; Preul MC
    J Neurosurg; 2011 Dec; 115(6):1131-8. PubMed ID: 21923240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer.
    Aziz D; Rawlinson E; Narod SA; Sun P; Lickley HL; McCready DR; Holloway CM
    Breast J; 2006; 12(4):331-7. PubMed ID: 16848842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
    Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
    Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines.
    Bernardi RJ; Lowery AR; Thompson PA; Blaney SM; West JL
    J Neurooncol; 2008 Jan; 86(2):165-72. PubMed ID: 17805488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein array technology to detect HER2 (erbB-2)-induced 'cytokine signature' in breast cancer.
    Vazquez-Martin A; Colomer R; Menendez JA
    Eur J Cancer; 2007 May; 43(7):1117-24. PubMed ID: 17379503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.